First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study.
Thomas BardolZahra Eslami-SDoryan MasmoudiMarie AlexandreMarie Duboys de LabarreAngélique BobrieVéronique D'HondtSéverine GuiuKeerthi KurmaLaure CayrefourcqWilliam JacotCatherine Alix-PanabièresPublished in: Cancer medicine (2023)
CTC assay is a promising tool that can be used for liquid biopsy in future clinical trials to stratify and monitor patients with cancer receiving anti-AXL therapies.
Keyphrases
- circulating tumor cells
- tyrosine kinase
- clinical trial
- poor prognosis
- circulating tumor
- squamous cell carcinoma
- small cell lung cancer
- high throughput
- current status
- ultrasound guided
- ionic liquid
- fine needle aspiration
- phase ii
- randomized controlled trial
- long non coding rna
- open label
- study protocol
- placebo controlled